Physical Factors in the Thromboplastic Activity of Phospholipids

Summary

Cephalin suspensions lose their thromboplastic activity when incubated with Tween or with sodium deoxycholate. This effect is proportional to the concentration of the surface-active substance, and to the length of its incubation with the phospholipids.

The disappearance of the thromboplastic activity of cephalin treated with surface-tension lowering substances is due to the increased dispersion of the suspensions, as demonstrated by the decrease of their optical density. The activity of sodium deoxycholate is faster than that of Tween.

The impaired thromboplastin formation in the presence of phospholipids treated with Tween or with sodium deoxycholate is not due to the formation of inhibitors.

Cephalin incubated with surface-tension lowering substances and recovered by ultracentrifugation does not show any thromboplastic activity.

Electron-microscopic studies show that incubation with surface-active substances causes the demolition of the structure of phospholipid-particle, on which the thromboplastic activity seems to depend.

The size of the particles and the electric surface-charge seem to be among the main factors responsible for the thromboplastic activity of phospholipids.

• References

• 1 Barkhan P, Newlands M. J, Wild F. Phospholipids from brain tissue as accelerators and inhibitors of blood coagulation. Lancet II: 234 1956;
• 2 Biggs B, Bidwell E. An attempt to identify a single phospholipid active in blood coagulation. Brit. J. Haemat 3: 387 1957;
• 3 Biggs R, Douglas A. S. The thromboplastin generation test, J, clin. Path 6: 23 1953;
• 4 Boyles P. W. Particle size as a factor in thromboplastin formation. Blood 14: 1063 1959;
• 5 Garrett J. W. The platelet-like activity of certain brain extracts. J. Lab. clin. Med 47: 752 1956;
• 6 Gobbi F. Lipidi e coagulazione del sangue. I. I lipidi tissulari, piastrinici e vegetali. Loro applicazioni terapeutiche. Boll. Soc. med.-chir. Modena 61: 429 1961;
• 7 Gobbi F, Antonucci M, Ascari E. Angioemofilia B. Haemat. lat. (Milano) 3: 363 1960;
• 8 Gobbi F, Ascari E, Barbieri U. Deficit congenito di proaccelerina (paraemofilia di Owren). Osservazioni cliniche e fisiopatologiche. Minerva med 51: 78 1960;
• 9 Gobbi F, Stefanini M. Coagulation defect of platelet-poor, lipid-free plasma: its correction by tissue phospholipids. Fed. Proc 17: 438 1958;
• 10 Gobbi F, Stefanini M. The coagulation defect of plasma poor in platelets and phospholipids. Its correction by tissue phospholipids. Acta heamat. (Basel) 21: 272 1959;
• 11 Horowitz H. I, Marcus A. J. The development of platelet factor 3 activity by latex particles. An interaction with plasma. Blood 23: 178 1964;
• 12 Marcus A. J, Spaet T. H. Platelet phosphatides: their separation, identification and clotting activity. J. clin. Invest 37: 1836 1958;
• 13 Marcus A. J, Oilman H. L, Wolfman M. Studies on blood platelet phosphatides. J. Lipid Res 1: 179 1960;
• 14 O’Brien J. R. The similarity of the action of phosphatidylethanolamine and platelets on blood coagulation. J. clin. Path 9: 47 1956;
• 15 Poole J. G. F, Robinson D. S. A comparison of the effect of certain phosphatides and of chylomicra on plasma coagulation in the presence of Russell’s viper venom. Quart. J. exp. Physiol 41: 31 1956;
• 16 Papahadjopoulos D, Hougie G, Hanahan D. J. Influence of surface charge of phospholipids on their clot-promoting activity. Proc. Soc. exp. Biol. (N. Y.) III: 412 1962;
• 17 Rapport M. M. Activation of phospholipid thromboplastin by lecithin. Nature (Lond.) 178: 591 1956;
• 18 Robinson D. S, Poole J. C. F. The similar effect of chylomicra and ethanolamine phosphatide on the generation of thrombin during coagulation. Quart. J. exp. Physiol 41: 36 1956;
• 19 Rouser G, Schloredt D. Phospholipid structure and thromboplastic activity. II. The fatty acid composition of the active phosphatidylethanolamine. Biochim. biophys. Acta (Amst.) 28: 81 1958;
• 20 Rouser G, White S. G, Schloredt D. Phospholipid structure and thromboplastic activity. I. The phosphatide fraction active in recalcified normal human plasma. Biochim. biophys. Acta (Amst.) 28: 71 1958;
• 21 Silver M. J, Turner D. L, Rodalewicz I, Giordano N, Holburn R, Herb S. F, Buddy F. E. Evaluation of activity of phospholipids in blood coagulation in vitro. Thrombos. Diathes. haemorrh. (Stuttg.) 10: 164 1963;
• 22 Stefanini M, Gobbi F. Studies on platelets XXIII. A cephalin complex and its fractions in the management of thrombocytopenic bleeding. Acta haemat. (Basel) 25: 145 1961;
• 23 Surgenor D. M, Wallach D. F. H. Biophysical aspects of platelet reaction mechanisms in clotting. In: Blood Platelets, Henry Ford Hospital International Symposium. 289 Little, Brown and Co.; Boston, Mass.: 1961
• 24 Troup S. B, Reed C. F, Marinetti G. V, Swisher S. N. Thromboplastin factors in platelets and red blood cells: observations on the chemical nature and function in “in vitro” coagulation. J. clin. Invest 39: 342 1960;
• 25 Turpini R. Aspetti chimici e fisici del meccanismo d’azione dei fosfolipidi nella coagulazione del sangue. Proc. XVIII Congr. It. Soc. Haemat. p. 339 E. M. E. S. Pubi., Rome, 1962.
• 26 Wallach D. F. H, Maurice P. A, Steele B. B, Surgenor D. M. Studies on the relationship between the colloidal state and clot-promoting activity of pure phosphatidylethanolamine. J. biol. Chem 234: 2828 1959;